Cardiolabs Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 13-01-2025
- Paid Up Capital ₹ 4.30 M
as on 13-01-2025
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.50 Cr
as on 13-01-2025
- Revenue 96.95%
(FY 2022)
- Profit 86.47%
(FY 2022)
- Ebitda 199.83%
(FY 2022)
- Net Worth 135.88%
(FY 2022)
- Total Assets 123.26%
(FY 2022)
About Cardiolabs Healthcare India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.30 M.
The company has closed loans amounting to ₹3.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ramesh Thakur and Shallu Thakur serve as directors at the Company.
- CIN/LLPIN
U33110PB2007PTC031136
- Company No.
031136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cardiolabs Healthcare India Private Limited offer?
Cardiolabs Healthcare India Private Limited offers a wide range of products and services, including Air Compressors, Accessories & Parts, Oil Free Air Compressor, Syringe Pump, Syringe Infusion Pump, Anaesthesia Machine, Medical Equipment & Accessories, ICU Ventilator.
Who are the key members and board of directors at Cardiolabs Healthcare India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Thakur  | Director | 15-May-2007 | Current |
| Shallu Thakur | Director | 15-May-2007 | Current |
Financial Performance of Cardiolabs Healthcare India.
Cardiolabs Healthcare India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 96.95% increase. The company also saw a substantial improvement in profitability, with a 86.47% increase in profit. The company's net worth Soared by an impressive increase of 135.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cardiolabs Healthcare India?
In 2020, Cardiolabs Healthcare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jul 2018 | ₹1.30 M | Satisfied |
Others Creation Date: 25 Jul 2016 | ₹2.37 Cr | Satisfied |
Central Bank Of India Creation Date: 31 Dec 2013 | ₹4.95 M | Satisfied |
How Many Employees Work at Cardiolabs Healthcare India?
Cardiolabs Healthcare India has a workforce of 39 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cardiolabs Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardiolabs Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
